Prot #APL2-GA-305: A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects with Geographic Atrophy Secondary to Age-Related Macular Degeneration

Project: Research project

Project Details

StatusActive
Effective start/end date9/13/21 → 9/30/25

Funding

  • Covance Inc. ((OE) Prot #APL2-GA-305 // (OE) Prot #APL2-GA-305)
  • Apellis Pharmaceuticals, Inc. ((OE) Prot #APL2-GA-305 // (OE) Prot #APL2-GA-305)